BGB-A317-15025-101
Active, not recruiting
BGB-15025 Alone and in Combination With Anti-PD-1 Monoclonal Antibody Tislelizumab in Participants With Advanced Solid Tumors
BeOne Study ID 
ClinicalTrials.gov ID
China Drug Trials ID
Study Overview
Sex:
All
Age: 18 Years / N/A
Accepts Healthy Volunteers? No
No Study Documents
Study Overview
Sex:
All
Age: 18 Years / N/A
Accepts Healthy Volunteers? No
No Study Documents